Blum Highlights Implications of CA-125 Levels in Renal Medullary Carcinoma

Dr Blum discusses renal medullary carcinoma, the lack of approved systemic therapy for these patients, and findings showing a correlation between CA-125 levels and increased tumor burden and treatment response in this disease.